Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 74.00
-1.00 (-1.33%)
Oct 8, 2026, 1:30 PM CST
Crystalvue Medical Market Cap
Crystalvue Medical has a market cap or net worth of 1.88 billion as of October 9, 2026. It is the 29,233rd most valuable company in the world and the 1,713th biggest in Taiwan. Its market cap has decreased by 13.65% in one year.
Market Cap
1.88B
Enterprise Value
1.83B
Revenue
874.21M
Global Rank
Country Rank
#1,713 Taiwan
PE Ratio
12.87
ChartMarket Cap Chart
Since April 29, 2015, Crystalvue Medical's market cap has increased from 1.04B to 1.88B, an increase of 80.70%. That is a compound annual growth rate of 5.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.88B | -2.76% |
| Dec 31, 2025 | 1.93B | -10.37% |
| Dec 30, 2024 | 2.15B | -1.77% |
| Dec 29, 2023 | 2.19B | 76.51% |
| Dec 30, 2022 | 1.24B | 8.45% |
| Dec 30, 2021 | 1.14B | -3.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bionime | 4.25B |
| ICARES Medicus | 3.73B |
| Maxigen Biotech | 3.42B |
| Nang Kuang Pharmaceutical | 3.36B |
| SciVision Biotech | 3.12B |
| BenQ Medical Technology | 1.78B |
| Chi Sheng Pharma & Biotech | 1.74B |
| Lagis Enterprise | 1.20B |